Literature DB >> 5100400

A proposed staging for children with neuroblastoma. Children's cancer study group A.

A E Evans, G J D'Angio, J Randolph.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5100400     DOI： 10.1002/1097-0142(197102)27:2<374::aid-cncr2820270221>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  135 in total

Review 1.  Neuroblastoma as a neurobiological disease.

Authors:  N F Schor
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Neuroblastoma with atypical metastases to cardiac and skeletal muscles: MRI features.

Authors:  Ricardo Faingold; Paul S Babyn; Shi-Joon Yoo; Anne I Dipchand; Sheila Weitzman
Journal:  Pediatr Radiol       Date:  2003-05-24

3.  Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.

Authors:  Rie Suganuma; Larry L Wang; Hideki Sano; Arlene Naranjo; Wendy B London; Robert C Seeger; Michael D Hogarty; Julie M Gastier-Foster; A Thomas Look; Julie R Park; John M Maris; Susan L Cohn; Gabriele Amann; Klaus Beiske; Catherine J Cullinane; Emanuele S G d'Amore; Claudio Gambini; Jason A Jarzembowski; Vijay V Joshi; Samuel Navarro; Michel Peuchmaur; Hiroyuki Shimada
Journal:  Pediatr Blood Cancer       Date:  2012-06-28       Impact factor: 3.167

4.  Intratumorous distribution of catecholaminergic clone cells of human neuroblastoma. A catecholamine fluorescence study.

Authors:  A Nakagawara; T Toyohara; K Ikeda; O Nada; M Tsuneyoshi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 5.  Screening for neuroblastoma.

Authors:  S N Huddart; J R Mann
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

6.  Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.

Authors:  Tadaharu Okazaki; Sumio Kohno; Jun-ichi Mimaya; Shiro Hasegawa; Naoto Urushihara; Atsushi Yoshida; Shinya Kawano; Junichi Kusafuka; Yasuo Horikoshi; Yoshifumi Takashima; Katsuhiko Aoki; Minoru Hamazaki
Journal:  Pediatr Surg Int       Date:  2003-12-19       Impact factor: 1.827

7.  High dose melphalan in children with advanced malignant disease. A pharmacokinetic study.

Authors:  J Ninane; R Baurain; A de Selys; A Trouet; G Cornu
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Prognostic value of different staging systems in neuroblastomas and completeness of tumour excision.

Authors:  N L Carlsen; I J Christensen; H Schroeder; P V Bro; U Hesselbjerg; K B Jensen; O H Nielsen
Journal:  Arch Dis Child       Date:  1986-09       Impact factor: 3.791

9.  Do infants with stage IV-S neuroblastoma need treatment?

Authors:  A E Evans; E Baum; R Chard
Journal:  Arch Dis Child       Date:  1981-04       Impact factor: 3.791

10.  Mechanism of direct spread of abdominal neuroblastoma: CT demonstration and clinical implications.

Authors:  M Oliphant; A S Berne
Journal:  Gastrointest Radiol       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.